Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is complex, with diverse therapeutic approaches and their combinations available ...

ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...

ReCerise Therapeutics Inc. ("ReCerise"), a company committed to research and development of first-in-class therapeutics in oncology, recently entered a research partnership with the National Cancer ...

A robot upgrade is transforming cancer surgery in South Carolina. The Da Vinci SP made its way to the operating room for ...

A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...

A mother of three who died days after receiving a liver cancer diagnosis is a tragically common case, a charity has said.

Hepatocellular carcinoma (HCC) is one of the deadliest cancers globally, with increasing incidence and mortality rates. It ...

A newly developed nomogram predicts preoperative microvascular invasion in patients with HCC, improving surgical planning and outcomes.

About Hepatocellular Carcinoma HCC is an aggressive cancer with rising mortality ... an estimated 70-80% of people with early-stage HCC experience disease recurrence following surgery. vi Early ...

Kate shared in a video statement that after undergoing abdominal surgery, tests showed "cancer had been present." "In January, I underwent major abdominal surgery in London and at the time, it was ...

In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative ...

Investigator Award has been awarded to two surgeon-scientists at the National Cancer Centre Singapore (NCCS) to pursue novel research in liver cancer and head and neck cancers. Globally, liver cancer ...